Follow The Filings

TEVA position history

The shares of Teva Pharmaceutical Industries (TEVA) that DME Capital Management reported in each quarter’s 13F.

Equity, SPONSORED ADS

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q1: 324,850 shares, $4.6M, 0.21% of portfolio
  2. 2024 Q2: 324,850 shares, $5.3M, 0.26% of portfolio
  3. 2024 Q3: 324,850 shares, $5.9M, 0.24% of portfolio
  4. 2024 Q4: 468,550 shares, $10M, 0.53% of portfolio, Add +44.2%
  5. 2025 Q1: 568,200 shares, $8.7M, 0.44% of portfolio, Add +21.3%
  6. 2025 Q2: 3,778,777 shares, $63M, 2.7% of portfolio, Add +565.0%
  7. 2025 Q3: 3,778,777 shares, $76M, 3.0% of portfolio
  8. 2025 Q4: 3,058,734 shares, $95M, 3.4% of portfolio, Reduce −19.1%
  9. 2026 Q1: 2,910,729 shares, $88M, 2.7% of portfolio, Reduce −4.8%
  10. 2026 Q2: 2,886,059 shares, $98M, 2.5% of portfolio, Reduce −0.8%
  11. 2026 Q3: not held, Exit
Holdings date Value % of holdings Shares Filing date All 13F holders